Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-076934
Filing Date
2019-12-30
Accepted
2019-12-30 21:31:01
Documents
2
Period of Report
2019-12-30

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1611
2 EX-24.1 ex-24d1.htm EX-24.1 10524
  Complete submission text file 0001104659-19-076934.txt   13473
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Issuer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROBO PHARMACEUTICALS, INC. 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115
Business Address
Shannon Nicola (Reporting) CIK: 0001795790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37809 | Film No.: 191317845